Astrana Health, Inc. (NASDAQ:ASTH) Receives Average Rating of “Moderate Buy” from Brokerages

Shares of Astrana Health, Inc. (NASDAQ:ASTH) have been assigned a consensus rating of “Moderate Buy” from the ten analysts that are currently covering the company, MarketBeat Ratings reports. Two equities research analysts have rated the stock with a hold recommendation and eight have given a buy recommendation to the company. The average 12-month price objective among brokerages that have updated their coverage on the stock in the last year is $49.8750.

Several equities research analysts recently weighed in on ASTH shares. Truist Financial raised their price target on shares of Astrana Health from $47.00 to $55.00 and gave the company a “buy” rating in a research report on Monday, August 10th. BTIG Research upped their price objective on Astrana Health from $50.00 to $65.00 and gave the company a “buy” rating in a research report on Tuesday, July 14th. Weiss Ratings reiterated a “hold (c)” rating on shares of Astrana Health in a research note on Thursday, August 27th. TD Cowen lifted their target price on Astrana Health from $45.00 to $50.00 and gave the stock a “buy” rating in a report on Tuesday, July 14th. Finally, Wall Street Zen cut Astrana Health from a “buy” rating to a “hold” rating in a research note on Sunday, August 16th.

Astrana Health Stock Performance

Shares of Astrana Health stock opened at $34.36 on Friday. Astrana Health has a 1 year low of $18.08 and a 1 year high of $51.60. The firm’s 50-day moving average is $38.98 and its 200 day moving average is $35.89. The stock has a market cap of $1.92 billion, a price-to-earnings ratio of 41.90 and a beta of 0.90. The company has a debt-to-equity ratio of 1.05, a current ratio of 1.23 and a quick ratio of 1.23.

Astrana Health (NASDAQ:ASTH) last released its quarterly earnings data on Thursday, August 6th. The company reported $0.80 earnings per share for the quarter, beating analysts’ consensus estimates of $0.34 by $0.46. The business had revenue of $972.52 million during the quarter, compared to analyst estimates of $985.62 million. Astrana Health had a net margin of 1.05% and a return on equity of 10.30%. Astrana Health’s revenue was up 48.5% compared to the same quarter last year. During the same period last year, the business earned $0.19 EPS. Sell-side analysts anticipate that Astrana Health will post 1.36 EPS for the current fiscal year.

Hedge Funds Weigh In On Astrana Health

A number of hedge funds have recently bought and sold shares of the business. Tidal Investments LLC bought a new stake in shares of Astrana Health in the second quarter worth approximately $974,000. Engineers Gate Manager LP bought a new position in Astrana Health during the second quarter valued at approximately $989,000. Corient Private Wealth LP boosted its holdings in Astrana Health by 1.6% in the second quarter. Corient Private Wealth LP now owns 24,905 shares of the company’s stock worth $1,156,000 after purchasing an additional 399 shares during the last quarter. VIRGINIA RETIREMENT SYSTEMS ET Al purchased a new stake in Astrana Health in the second quarter worth approximately $529,000. Finally, Public Employees Retirement System of Ohio bought a new stake in Astrana Health in the 2nd quarter worth approximately $51,000. Hedge funds and other institutional investors own 52.77% of the company’s stock.

About Astrana Health

Astrana Health, Inc is a healthcare management and technology company that helps physicians and healthcare organizations deliver value-based care. The company supports provider groups, independent physicians and health systems with clinical, operational and administrative services designed to coordinate care, improve outcomes and manage healthcare costs.

Astrana Health’s platform includes care-management programs, analytics and population-health tools, technology solutions, physician practice support, and services for risk-bearing provider organizations.